Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide
- 1 May 1979
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 24 (20), 1907-1912
- https://doi.org/10.1016/0024-3205(79)90243-1
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Sustained Elevation of Serum Prolactin by Metoclopramide: A Clinical Model of Idiopathic Hyperprolactinemia*Journal of Clinical Endocrinology & Metabolism, 1978
- An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levelsAmerican Journal of Psychiatry, 1977
- Effect of metoclopramide on rat prolactin secretionLife Sciences, 1977
- DOPAMINE RECEPTOR BLOCKING ACTIVITY OF SULPIRIDE IN THE CENTRAL NERVOUS SYSTEMThe Japanese Journal of Pharmacology, 1977
- Comparative Psychotropic Effects of Metoclopramide and Prochlorperazine in Normal SubjectsThe Journal of Clinical Pharmacology, 1975
- SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDEJournal of Neurochemistry, 1975
- Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsPsychopharmacology, 1975
- Antipsychotic drugs stimulate prolactin releasePsychopharmacology, 1974
- Inhibition of the apomorphine gnawing compulsion by amantadineCellular and Molecular Life Sciences, 1973
- Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?Psychopharmacology, 1973